CHUGAI PHARMA UNSUP ADR - CS (CHGCY)

Historical Holders from Q1 2017 to Q3 2025

Symbol
CHGCY
Type / Class
Equity / CS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
140,494
Holdings value
$3,094,381
% of all portfolios
0%
Number of holders
8
Number of buys
2
Number of sells
-9
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CHUGAI PHARMA UNSUP ADR - CS (CHGCY)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 140,494 $3,094,381 -$860,539 $22.11 8
2025 Q2 177,534 $4,626,291 +$61,685 $26.07 12
2025 Q1 175,170 $3,983,186 +$404,396 $22.74 11
2024 Q4 157,400 $3,478,355 -$359,564 $21.97 7
2024 Q3 172,761 $4,171,984 -$3,911,046 $24.09 8
2024 Q2 323,971 $5,756,959 +$525,080 $17.77 6
2024 Q1 293,340 $5,611,597 +$200,772 $19.13 9
2023 Q4 282,883 $5,326,910 -$320,150 $18.85 8
2023 Q3 294,427 $4,531,526 -$295,856 $15.39 6
2023 Q2 313,684 $4,464,886 -$3,136,050 $14.19 6
2023 Q1 571,378 $7,017,491 +$1,297,008 $12.28 6
2022 Q4 465,771 $5,902,444 +$2,700,566 $12.67 4
2022 Q3 252,565 $3,143,000 -$4,016,910 $12.49 3
2022 Q2 286,130 $3,654,000 +$374,044 $12.77 3
2022 Q1 472,111 $7,871,000 +$875,313 $16.71 5
2021 Q4 419,593 $6,861,000 -$1,463,761 $16.36 5
2021 Q3 484,112 $8,889,000 +$4,881,247 $18.36 9
2021 Q2 218,255 $4,343,000 -$26,864,303 $19.91 5
2021 Q1 1,541,688 $31,294,011 -$5,652,914 $20.29 9
2020 Q4 1,738,494 $46,266,416 +$4,305,264 $26.6 10
2020 Q3 1,576,618 $35,290,824 +$32,278,993 $22.4 9
2020 Q2 125,955 $41,101,157 +$10,874,948 $326.09 9
2020 Q1 92,691 $21,268,371 -$6,972,306 $227.69 8
2019 Q4 122,550 $22,731,723 -$22,365 $185.44 8
2019 Q3 123,103 $19,117,382 +$16,197,301 $154.9 8
2019 Q2 18,871 $2,483,000 +$1,127,519 $130.47 5
2019 Q1 10,327 $1,425,000 +$923,177 $137.96 4
2018 Q4 3,621 $420,000 -$22,154 $115.99 1
2018 Q3 3,812 $397,000 -$7,186 $104.14 1
2018 Q2 3,881 $435,000 -$30,375 $112.08 1
2018 Q1 4,152 $428,000 -$22,987 $103.08 1
2017 Q4 4,375 $447,000 -$25,645 $102.17 1
2017 Q3 4,626 $381,000 +$5,106 $82.36 1
2017 Q2 4,564 $351,000 -$12,459 $76.91 1
2017 Q1 4,726 $332,000 +$332,000 $70.25 1